Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply constraints.
17don MSN
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
FRANKFURT, Feb 19 (Reuters) - The European Union's healthcare regulator will this week review the use of Eli Lilly's LLY.N approved Mounjaro drug against diabetes and obesity when prefilled in a multi ...
Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results